查找临床试验
已按「膀胱癌」检索，对应国际通用词 bladder cancer
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:18，每 5 分钟自动同步Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma
Hong Kong
年龄 18 Years – 70 Years
Yung NA
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
United States、Australia、Canada、China、Denmark 等 11 国
年龄 18 Years – 不限
Bayer
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
China
年龄 18 Years – 75 Years
RemeGen Co., Ltd.
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
United States、Australia、Canada、China、France 等 12 国
年龄 18 Years – 不限
Eli Lilly and Company
The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
China
年龄 18 Years – 85 Years
RenJi Hospital
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
China
年龄 18 Years – 不限
Suzhou Forlong Biotechnology Co., Ltd
Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients
China
年龄 18 Years – 不限
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer
China
年龄 18 Years – 不限
Shanxi Province Cancer Hospital
Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
China
年龄 18 Years – 不限
First Affiliated Hospital of Chongqing Medical University
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
China
年龄 18 Years – 不限
Zhuhai Beihai Biotech Co., Ltd
Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study
China
年龄 18 Years – 85 Years
Peking University First Hospital
DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC
China
年龄 18 Years – 不限
Fudan University